Following the exclusion of synonymous mutations, we detected 57 and 140 BRCA1 and BRCA2 mutations, respectively, in the blood of CRC patients, suggesting that BRCA1, and BRCA2 mutations in the blood were more prevalent than those found in the tissue of CRC patients. This evidence concerns the gene BRCA2 and colorectal carcinoma.